| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 05/24/2006 | CN1775779A Diphenyl ether azole derivative bioelectronic transmission material, and its new preparing method and use |
| 05/24/2006 | CN1775759A Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 05/24/2006 | CN1257167C N-teriary-butyl-2 (benzothiazyl) sulfenamide and production process thereof |
| 05/23/2006 | US7049444 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
| 05/23/2006 | US7049443 Such as 2-(3-(Acetyl(((5S)-3-(4-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-3 -fluorophenyl)-2-oxo-1,3-oxazolidin-5-yl)meth yl)amino)-1,1-dimethyl-3-oxopropyl)-3,5-dimethylphenyl dihydrogen phosphate; improved bioavailability |
| 05/23/2006 | US7049438 Quinazoline derivatives for treatment of tumours |
| 05/23/2006 | US7049331 1,2,4-thiadiazole derivatives as melanocortin receptor modulators |
| 05/23/2006 | US7049321 Methods and pharmaceutical compositions for treatment of central and peripheral nervous system disorders and compounds useful therefor |
| 05/23/2006 | US7049313 Induce immunology response; anticancer agents |
| 05/23/2006 | US7049312 2H-1,4-benzothiazin-3(4H)-one derivative as anticarcinogenic and antiproliferative agent; inhibitors of serine/threonine and tyrosine kinase activity |
| 05/23/2006 | US7049309 Administering a therapeutically effective amount of 3-thia-4-(2-oxy/hydroxyphenyl)quinolin-2-one derivative to a patient to treat erectile dysfunction or irritable bowel syndrome |
| 05/23/2006 | US7049306 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4. |
| 05/23/2006 | CA2291134C Method for the preparation of citalopram |
| 05/23/2006 | CA2257200C Substituted imidazoles having cytokine inhibitory activity |
| 05/23/2006 | CA2242494C Novel n-substituted 4-((4'-aminobenzoyl)-oxymethyl)-piperidines having gastric prokinetic properties |
| 05/23/2006 | CA2122270C Tri-substituted tetrahydrofuran antifungals |
| 05/18/2006 | WO2006053112A1 Process for preparing trisubstituted pyrimidine compounds |
| 05/18/2006 | WO2006053109A1 Heteroaryl compounds |
| 05/18/2006 | WO2006052810A2 Combination of a src kinase inhibitor and a bcr-abl inhibitor for the treatment of proliferative diseases |
| 05/18/2006 | WO2006051892A1 Method for preparing azetidinone derivative |
| 05/18/2006 | WO2006051826A1 Nitrogenous heterocyclic compound and pharmaceutical use thereof |
| 05/18/2006 | WO2006051704A1 Imine compound |
| 05/18/2006 | WO2006051662A1 Thiazole derivative |
| 05/18/2006 | WO2006051270A1 5-heteroaryl thiazoles and their use as p13k inhibitors |
| 05/18/2006 | WO2006051202A1 Derivatives of 4,7-dioxobenzothiazole-2-carboxamides, preparation method thereof and therapeutic uses of same |
| 05/18/2006 | WO2006038006A3 5-sulfonyl-1-piperidinyl substituted indole derivatives as 5-ht6 receptor antagonists for the treatment of cns disorders |
| 05/18/2006 | WO2006023931A3 Kinase inhibitors |
| 05/18/2006 | WO2006018188A3 Substituted hydantoins |
| 05/18/2006 | WO2005116653A3 Modulators of human g protein-coupled receptors for the treatment of hyperglycemia and related disorders |
| 05/18/2006 | WO2005082884A3 2-pyridin-2yl-pyrimidine derivatives useful in the treatment of gastro-esophagea l reflux disease |
| 05/18/2006 | WO2005077945A3 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors |
| 05/18/2006 | WO2005051301A3 Heterocyclic inhibitors of mek and methods of use thereof |
| 05/18/2006 | US20060106221 Process for the preparation of thiazolidinedione derivatives |
| 05/18/2006 | US20060106211 Group 9 or 10 metal complexes of N-(N-heterocycle-substuted)acridines, phenoxazines and phenothiazines that are capable of converting a triplet excitation state into light emission and excellent in heat resistance; electronic devices with low power consumption |
| 05/18/2006 | US20060106078 Prostamide receptor antagonists |
| 05/18/2006 | US20060106075 Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity |
| 05/18/2006 | US20060106073 Process for the preparation of epothilone derivatives, new epothilone derivatives as well as new intermediate products for the process and the methods of preparing same |
| 05/18/2006 | US20060106062 Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors |
| 05/18/2006 | US20060106061 PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 05/18/2006 | US20060106042 Substituted heterocyclpyrmidines |
| 05/18/2006 | US20060106034 Drug efflux pump inhibitor |
| 05/18/2006 | US20060106031 Novel heterocyclyls as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 05/18/2006 | US20060106029 antitumor agent; 6-((4-(3-chloro-2-fluorobenzoyl)piperazin-1-yl) methyl)-N-thiazol-2-ylpyridin-2-amine; excellent potentiation; side effects reduction |
| 05/18/2006 | US20060106015 Novel use of benzothiazole derivatives |
| 05/18/2006 | US20060106011 2-(Bicyclo)alkylamino-derivatives as mediators of chronic pain and inflammation |
| 05/18/2006 | US20060105997 Mitotic kinesin inhibitors |
| 05/18/2006 | CA2587667A1 Imine compound |
| 05/18/2006 | CA2586649A1 Combination of a src kinase inhibitor and a bcr-abl inhibitor for the treatment of proliferative diseases |
| 05/18/2006 | CA2586355A1 Derivatives of 4,7-dioxobenzothiazole-2-carboxamides, preparation method thereof and therapeutic uses of same |
| 05/18/2006 | CA2585310A1 5-heteroaryl thiazoles and their use as p13k inhibitors |
| 05/17/2006 | EP1657954A1 Transmitter of wireless microphone, receiver for wireless microphone, mobile information communication apparatus, and communication system for wireless microphone |
| 05/17/2006 | EP1656377A1 Aminobenzimidazole derivatives |
| 05/17/2006 | EP1656374A1 Thiazole derivatives as npy antagonists |
| 05/17/2006 | EP1656373A2 Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and use of same as chemokineantagonists |
| 05/17/2006 | EP1656372A2 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases |
| 05/17/2006 | EP1656370A2 Biaryl heterocyclic compounds and methods of making and using the same |
| 05/17/2006 | EP1656353A1 Gabanergic modulators |
| 05/17/2006 | EP1656345A1 Cyclic derivatives as modulators of chemokine receptor activity |
| 05/17/2006 | EP1656096A2 Methods of reducing risk of infection from pathogens |
| 05/17/2006 | EP1656020A2 Pyridinylanilides |
| 05/17/2006 | EP1345929B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345927B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345926B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345925B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1317452B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1317447B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1109787B1 Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp) |
| 05/17/2006 | CN1774437A 7-([1,4]dioxan-2-yl)-benzothiazole derivatives as adenosine receptor ligands |
| 05/17/2006 | CN1774428A M-stage kinesin inhibitor |
| 05/17/2006 | CN1774418A Substituted N-arylheterocycles, method for production and use thereof as medicaments |
| 05/17/2006 | CN1772751A Substituted oxazolidinones and their use in the field of blood coagulation |
| 05/17/2006 | CN1771943A Novel method of treatment |
| 05/17/2006 | CN1256329C Herbicidal substituted benzoylpyrazoles |
| 05/17/2006 | CN1256328C Position seven substituted amine methyl fluoro quinolone derivative having antibacterial activity and its preparation method |
| 05/17/2006 | CN1256326C 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency |
| 05/17/2006 | CN1256324C Pyrrolidine derivatives as factor Xa inhibitors |
| 05/16/2006 | US7045633 Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt |
| 05/16/2006 | US7045631 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands |
| 05/16/2006 | US7045544 Myocardium; angina pectoris |
| 05/16/2006 | US7045539 Therapeutic benzoxazole compounds |
| 05/16/2006 | US7045526 Substituted 4-amino-2-aryl-tetrahydroquinazolines, their preparation, their use and pharmaceutical preparations comprising them |
| 05/16/2006 | US7045517 Triazine compounds |
| 05/16/2006 | US7045514 Therapeutic heterocyclic compounds |
| 05/16/2006 | CA2244903C Hydroxamic acid derivatives for use with the treatment of diseases related to connective tissue degradation |
| 05/16/2006 | CA2192797C Indolinone compounds for the treatment of disease |
| 05/11/2006 | WO2006050506A1 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 05/11/2006 | WO2006049734A2 Quetiapine analogs and methods of use thereof |
| 05/11/2006 | WO2006048209A1 Novel bradykinin b1 antagonists, method for producing the same and the use thereof as drugs |
| 05/11/2006 | WO2006047893A1 Process for the preparation of ziprasidone (5-[2-[4-(1,2-benzisothiazol-3-y1)-1-piperaziny1]ethy1]-6-chloro-1,3-dihydro-2h-indol-2-one) |
| 05/11/2006 | WO2005101838A8 Piperazinylpiperidine derivatives as chemokine receptor antagonists |
| 05/11/2006 | WO2005086892A3 Ion channel modulators |
| 05/11/2006 | WO2005012275A3 Benzo [1, 2, 5] thiadiazole compounds as cck2 modulators |
| 05/11/2006 | US20060100442 Reacting 2-{[(S)-2-methylpent-4-in-1-yl]oxy}-3,4,5,6-tetrahydro-2H-pyrane with acetaldehyde to produce 2RS,6S)-6-Methyl-7-[(RS)-(3,4,5,6-tetrahydro-2H-pyran-2-yl)oxy]hept-3-in-2-ol |
| 05/11/2006 | US20060100427 Alzheimer's disease and other diseases relating to amyloid deposits; neurodegenerative diseases |
| 05/11/2006 | US20060100425 Indole acetic acids exhibiting CRTH2 receptor antagonism and uses thereof |
| 05/11/2006 | US20060100261 Furan or thiopene derivative and medicinal use thereof |
| 05/11/2006 | US20060100259 Process for the preparation of substituted triazole compounds |
| 05/11/2006 | US20060100255 Substituted indolealkanoic acids derivative and formulations containing same for use in the treatment of diabetic complications |
| 05/11/2006 | US20060100253 Novel compounds for the treatment of neurological disorders |
| 05/11/2006 | US20060100249 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses |